|
is a technically innovative software company that specializes in highly profitable
information management systems for cardiac medicine.
CardioComm's patented systems enable medical professionals to access and manage
patient information from a variety of devices regardless of time or location.
The Company's FDA approved software enables electrocardiography (ECG) data to be
transmitted, received and managed anywhere in the world using standard computers,
wireless devices, enterprise networks, telephones, or the Internet.
This is a break through in the field of cardiac software. In North America alone,
there are over 2 million ECG tests completed everyday. Therefore, this is truly
a large marketplace considering 1 in 4 Americans is over 50 years of age. Given the aging demographics and the need for cardiovascular testing, 12 lead ECG will continue to be one of the most frequently performed tests in the physicians office or the hospital.
CardioComm has 2 primary product divisions. GlobalCardio™ (Internet-12 Lead
Management) and GEMS™(PC-Arrhythmia Management).
|